NDRG1 Recombinant Monoclonal Antibody

Code CSB-RA835678A0HU
Size US$210
Order now
Image
  • Western Blot
    Positive WB detected in: Hela whole cell lysate, 293T whole cell lysate, PC3 whole cell lysate, U87 whole cell lysate, Mouse kidney tissue
    All lanes: NDRG1 antibody at 0.7μg/ml
    Secondary
    Goat polyclonal to rabbit IgG at 1/50000 dilution
    Predicted band size: 43, 36, 34 KDa
    Observed band size: 43 KDa
  • IHC image of CSB-RA835678A0HU diluted at 1:71.6666666666667 and staining in paraffin-embedded human breast cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4℃ overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
  • Immunofluorescence staining of Hela cells with CSB-RA835678A0HU at 1:23, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4℃. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG (H+L).
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
NDRG1
Alternative Names
42 kDa antibody; Anti GC4 antibody; cap43 antibody; cmt4d antibody; Differentiation related gene1 protein antibody; Differentiation-related gene 1 protein antibody; Drg 1 antibody; DRG-1 antibody; drg1 antibody; gc4 antibody; GC4 antibody antibody; hmsnl antibody; Human mRNA for RTP complete cds antibody; N myc downstream regulated gene 1 antibody; N myc downstream regulated gene 1 protein antibody; N-myc downstream-regulated gene 1 protein antibody; Ndr 1 antibody; ndr1 antibody; NDRG 1 antibody; Ndrg1 antibody; NDRG1 protein antibody; NDRG1_HUMAN antibody; Nickel specific induction protein antibody; Nickel specific induction protein Cap43 antibody; Nickel-specific induction protein Cap43 antibody; nmsl antibody; Nmyc downstream regulated antibody; Nmyc downstream regulated gene1 antibody; Nmyc downstream regulated gene1 protein antibody; Protein NDRG1 antibody; Protein regulated by oxygen 1 antibody; Protein regulated by oxygen1 antibody; Proxy1 antibody; Reduced in tumor antibody; Reducin antibody; Reducing agents and tunicamycin responsive protein antibody; Reducing agents and tunicamycin-responsive protein antibody; Rit42 antibody; RTP antibody; targ1 antibody; TDD5 antibody; tdds antibody; Tunicamycin responsive protein antibody
Species Reactivity
Human, Mouse
Immunogen
A synthesized peptide derived from human NDRG1
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Monoclonal
Isotype
Rabbit IgG
Clone No.
4C8
Purification Method
Affinity-chromatography
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Form
Liquid
Tested Applications
ELISA, WB, IHC, IF
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:5000
IHC 1:50-1:200
IF 1:20-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Description

The recombinant NDRG1 antibody is a monoclonal antibody made in vitro using the NDRG1 antibody genes that are typically expressed from a plasmid in a stable mammalian cell line. The genes coding for the NDRG1 antibody will ultimately assemble into a fully functional antibody after translation. The synthesized antibody is the recombinant antibody against NDRG1. It underwent purification using affinity-chromatography. This recombinant NDRG1 antibody is suitable for use in the ELISA, WB, IHC, IF to detect the NDRG1 protein from Human, Mouse.

NDRG1 as a prognostic factor in breast cancer remains controversial, as it continues to be cited as both a biomarker of negative prognosis and as a metastasis suppressor. Although its function is poorly defined, NDRG1 is a direct transcriptional target of hypoxia inducible factor 1α (Hif1α), Hif2α, and X-box binding protein 1 (XBP1). NDRG1 protein expression has been associated with high uptake of 18-fluorodeoxyglucose and estrogen receptor (ER)-negative breast cancers in vivo, but rather than a role in glycolysis, physical interactors and physiological consequences of NDRG1 malfunction suggest a poorly defined role related to lipid biology in cancer. NDRG1 is expressed in a Warburg-like metabolic gene expression program common to many solid tumors, including breast cancer. Several lines of evidence show that NDRG1 performs an important pro-survival function in regulating the fate of lipids in breast cancer cells. Increased NDRG1 expression suppresses angiogenesis via PI3K/AKT pathway in human placental cells.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Stress-responsive protein involved in hormone responses, cell growth, and differentiation. Acts as a tumor suppressor in many cell types. Necessary but not sufficient for p53/TP53-mediated caspase activation and apoptosis. Has a role in cell trafficking, notably of the Schwann cell, and is necessary for the maintenance and development of the peripheral nerve myelin sheath. Required for vesicular recycling of CDH1 and TF. May also function in lipid trafficking. Protects cells from spindle disruption damage. Functions in p53/TP53-dependent mitotic spindle checkpoint. Regulates microtubule dynamics and maintains euploidy.
Gene References into Functions
  1. These findings indicate that NDRG1 expression is associated with both prognosis and c-Myc expression in lung adenocarcinoma PMID: 29431240
  2. Meta-analysis showed that low NDRG1 expression was significantly associated with worse survival in colorectal cancer and pancreatic cancer but higher survival of patients with liver cancer and gallbladder cancer. No significant association was observed between low NDRG1 expression and survival in gastric cancer or esophageal cancer. PMID: 30313035
  3. Findings indicate a positive feedback loop between cancer associated fibroblast (CAFs) and box Q1 (FOXQ1)/N-myc downstream-regulated gene 1 (NDRG1) axis in neoplastic cells to drive hepatocellular carcinoma (HCC) initiation, suggesting new potential therapeutic targets for HCC. PMID: 29248714
  4. In summary, CAPE attenuates Nasopharyngeal carcinoma (NPC)cell proliferation and invasion by upregulating NDRG1 expression via MAPK pathway and by inhibiting phosphorylation of STAT3. Considering the poor prognosis of NPC patients with metastasis, CAPE could be a promising agent against NPC. PMID: 29738439
  5. These results indicate the N-terminus region and phosphorylation at Ser330 could be crucial for NDRG1 nuclear localization and function. PTEN silencing indicated that p-NDRG1 (Thr346) could be regulated differentially in different tumor cell-types, indicating PTEN may be involved in the mechanism(s) underlying the pleiotropic activity of NDRG1. PMID: 29679718
  6. present study shows that HER4 and/or NDRG1 might play a critical role for the cell survival and chemo-resistance of Osteosarcoma (OS), and could be used as potential therapeutic targets in OS. PMID: 29524631
  7. our study described two homozygous missense mutations in NDRG1 in CMT patients and mentioned the function of NDRG1 in protein recycling, which plays an important role in myelination of the peripheral nerve system. PMID: 28776325
  8. NDRG1 over-expression promoted apoptosis in colorectal cancer cells whereas depletion of NDRG1 resulted in resistance to oxaliplatin treatment. PMID: 28537875
  9. HCV coopts the MYC pathway responsible for NDRG1 expression and phosphorylation that regulates lipid droplet formation and metabolism. NDRG1 appears to restrict HCV by suppressing the lipid droplet formation that is necessary for HCV assembly. PMID: 29118118
  10. these data show that NDRG1 is regulated by the oncogenic MAP kinase-interacting kinase pathway, a target for cancer therapy PMID: 28545025
  11. The research findings provide novel insights suggesting that loss of N-myc downregulated gene 1 (NDRG1) leads to a decrease in actin-mediated cellular motility but an increase in cellular invasion, resulting in increased tumor dissemination which positively impacts metastatic outcome. PMID: 28371345
  12. Our experiments revealed that long-term (24 h), but not short-term hypoxia led to the induction of NDRG1 expression in human glioma cell lines. NDRG1 expression was found to correlate with the protein expression of HIF-1alpha, SP1, CEBPalpha, YB-1 and Smad7 PMID: 28498432
  13. Data show that LSD1 affects motility and invasiveness of neuroblastoma cells by modulating the transcription of the metastasis suppressor NDRG1. Mechanistically, results found that LSD1 co-localizes with MYCN at the promoter region of the NDRG1 gene and inhibits its expression. PMID: 27894074
  14. Compared with the normal term pregnancies, the expression of both NDRG1 mRNA and protein were significantly high in placentas from preeclampsia, and the expression of NDRG1 in early-onset preeclampsia was higher than that in late-onset preeclampsia. PMID: 28292472
  15. we demonstrated that the novel molecule of cell migration and invasion, caveolin-1, has direct interaction with NDRG1 in human colorectal cancer cells PMID: 28346422
  16. strong NDRG1 expression in ciliated epithelial cells in nasal tissues sampled from patients with chronic rhinosinusitis. NDRG1 gene knockdown decreased the transepithelial electrical resistance and increased the dextran permeability. NDRG1 knockdown disrupted tight junctions of airway epithelial cells. NDRG1 knockdown significantly decreased only claudin-9 expression, but did not decrease other claudin family molecules. PMID: 28191699
  17. Study elucidates a mechanism of NDRG1-regulated Wnt pathway activation and EMT via affecting TLE2 and beta-catenin expression in esophageal cancer cells. PMID: 27414086
  18. NDRG1 prevented the degradation of c-Myc through Skp2-mediated ubiquitination in tumor cells. NDRG1 directly interacted with Skp2, and decreased phosphorylation of Skp2 through inactivation of CDK2. PMID: 28456659
  19. Data suggest that NDRG1 attenuates oncogenic signaling by inhibiting formation of EGFR/HER2 and HER2/HER3 heterodimers and by down-regulating EGFR via a mechanism involving its degradation. (NDRG1 = N-myc downstream regulated gene 1 protein; EGFR = epidermal growth factor receptor; HER = human epidermal growth factor receptor) [REVIEW] PMID: 28615452
  20. NDR1 interacts with TRAF3 and interferes with the association of TRAF3 and IL-17R, resulting in increased formation of the activation complex IL-17R-Act1, which is required for the downstream signaling and production of pro-inflammatory factors PMID: 28219902
  21. NDRG1 overexpression leads to reduced tumor growth and angiogenesis in experimental glioma via upregulation of TNFSF15. In NDRG1 overexpressing glioma antiangiogenic treatment does not yield a therapeutic response. PMID: 26297987
  22. The current study is the first to elucidate a unique facet of the potent tumor/metastasis suppressor NDRG1 in the regulation of pancreatic ductal adenocarcinoma (PDAC)glycolysis, leading to important insights into the mechanism by which NDRG1 exert inhibitory function in PDAC. PMID: 28350132
  23. The mean nerve NDRG1 expression score was 5.4. PMID: 27716814
  24. Hereditary motor and sensory neuropathy-type Lom in 12 Czech patients, carrying NDRG1 mutation and one unusual case due to uniparental isodisomy of chromosome 8 has been reported. PMID: 28003645
  25. Authors confirm that the decrease of GOLPH3 that promotes the apoptosis of glioma cells may be regulated by the activation of NDRG1 and cleaved capcase 3. There was a inverse association between GOLPH3 and NDRG1 in glioma samples. PMID: 27698340
  26. NDRG1 role in proliferation, invasion and migration of pancreatic cancer PMID: 28075464
  27. Cell proliferation and invasion effect were remarkably enhanced when NDRG1 was silencing. PMID: 27154576
  28. NDRG1 appears to prevent epithelial-mesenchymal transition (EMT)-induced metastasis by attenuating NF-kappaB signaling in metastasis of colorectal cancer (CRC). PMID: 27338835
  29. The positive rates of NDRG1expression was 63. 83.33% (40/48)and 27.78% (5/18) in the controls, respectively. High expressions of NDRG1 and VEGF, NDRG1 and VEGF influenced both the occurrence and development of CA PMID: 27655496
  30. Also, overexpression of AHR facilitated cell proliferation and migration via up-regulation of NDRG1. PMID: 26852918
  31. NDRG1 inhibits stemness of colorectal cancer via down-regulation of nuclear beta-catenin and CD44 PMID: 26418878
  32. Data suggest that, in colonic/prostatic neoplasm cells, increased expression of NDRG1 decreases activating phosphorylation of FAK and paxillin; silencing/inhibition of NDRG1 results in opposite effect and inhibits neoplasm cell migration/adhesion. PMID: 26895766
  33. Data indicate that N-myc downstream regulated gene 1 (NDRG1) competitively bind to glycogen synthase kinase 3beta (GSK-3beta) and orphan nuclear receptor (Nur77) to prevent beta-catenin degradation. PMID: 26359353
  34. Data suggest that NDRG1 down-regulates expression and activation of HER1/EGFR, HER2/ERBB2, and HER3/ERBB3 in response to epidermal growth factor (EGF) ligand in pancreatic/colonic neoplasm cells. PMID: 26534963
  35. pomegranate juice-mediated decrease in cell death in hypoxia is partially mediated by NDRG1 in BeWo cells but not in primary trophoblasts. PMID: 26028238
  36. Results show that aberrant methylation of NDRG1 promoter is an important mechanism for gene silencing, playing a major role in tumor occurrence and progression of protate cancer (Pca). Reversing this process may be used for PCa treatment. PMID: 26202882
  37. NDRG1 could increase the resistance of neuroblastoma cells to chemotherapeutic drugs, with its positive regulation on drug resistant proteins. PMID: 26653549
  38. NDRG1 decreases phosphorylation of c-Src at Tyr416 by down-regulating EGFR expression and activation. It also affected Rac1, p130Cas, CrkII, and c-Abl. NDRG1 decreases cell migration via c-src inhibition. PMID: 25860930
  39. no significant difference in serum levels between pre-eclampsia and normotensive PMID: 25110805
  40. Overexpression of NDRG1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways. PMID: 25777142
  41. TP53 loss leads to abnormal centrosome numbers and genomic instability mediated by NDRG1 PMID: 26324937
  42. Down-regulation of NDRG1 in gastric cancer metastatic progression was correlated to E-cadherin and MMP-9. NDRG1 acts as a tumor suppressor gene. PMID: 24985974
  43. GLI1 expression in both H441 and PW cells was associated with increased expression of NDRG1, a gene known to be downregulated by the MYC family of proteins, indicating that upregulation of NDRG1 by GLI1 is not cell-type specific. PMID: 26349604
  44. miR-769-3p can functionally regulate NDRG1 during changes in oxygen concentration. PMID: 25081069
  45. A functional link between SET-mediated NDRG1 regulation. PMID: 25152373
  46. Variants of NDRG1 mRNA were transcriptionally regulated after HepG2 and MCF-7 cells were treated by iron chelators, resulting in domination of NDRG1 mRNA Variant 1 (V1) in the HepG2 calls and domination of NDRG1 mRNA Variant 2 (V2) in the MCF-7 cells PMID: 25335733
  47. NDRG1 is SUMOylated at Lysine 14.SUMO modification destabilizes the protein stability of NDRG1. PMID: 25712528
  48. NDRG1 as a molecular target to inhibit the epithelial-mesenchymal transition: the case for developing inhibitors of metastasis--{review} PMID: 25162997
  49. NDRG1 is shown to modulate the WNT-beta-catenin pathway by inhibiting the nuclear translocation of beta-catenin. PMID: 24829151
  50. Microarray analyses of cellular gene expression identified N-myc downstream regulated gene 1 (NDRG1) as a putative target of Epstein-Barr virus BamHI A rightward transcripts (BART) locus miRNAs. PMID: 25520514

Show More

Hide All

Involvement in disease
Charcot-Marie-Tooth disease 4D (CMT4D)
Subcellular Location
Cytoplasm, cytosol. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Nucleus. Cell membrane. Note=Mainly cytoplasmic but differentially localized to other regions. Associates with the plasma membrane in intestinal epithelia and lactating mammary gland. Translocated to the nucleus in a p53/TP53-dependent manner. In prostate epithelium and placental chorion, located in both the cytoplasm and in the nucleus. No nuclear localization in colon epithelium cells. In intestinal mucosa, prostate and renal cortex, located predominantly adjacent to adherens junctions. Cytoplasmic with granular staining in proximal tubular cells of the kidney and salivary gland ducts. Recruits to the membrane of recycling/sorting and late endosomes via binding to phosphatidylinositol 4-phosphate. Associates with microtubules. Colocalizes with TUBG1 in the centrosome. Cytoplasmic location increased with hypoxia. Phosphorylated form found associated with centromeres during S-phase of mitosis and with the plasma membrane.
Protein Families
NDRG family
Tissue Specificity
Ubiquitous; expressed most prominently in placental membranes and prostate, kidney, small intestine, and ovary tissues. Also expressed in heart, brain, skeletal muscle, lung, liver and pancreas. Low levels in peripheral blood leukocytes and in tissues of
Database Links

HGNC: 7679

OMIM: 601455

KEGG: hsa:10397

STRING: 9606.ENSP00000319977

UniGene: Hs.372914

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalization X
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*